Jason Xenakis

Jason Xenakis

Senior Market Access Analyst

Share this

Jason is the Senior Market Access Analyst at WG providing expertise in health economics and market access in the areas of pharmaceuticals, medical devices and diagnostics.

Prior to joining WG Group, Jason worked as a consultant at GfK leading projects focused on global engagements across a spectrum of product launch, lifecycle, pricing, health economic and market access challenges in a broad range of disease indications, including neuropsychiatric disorders, immunology, diabetes, oncology, asthma, and infectious disease.

Jason previously worked as a Senior Scientist at Merck & Co., Inc., in the Molecular Biomarkers department. Here, he was responsible for determination of specific molecular targets for development of clinical diagnostics, as well as preclinical assays for development of novel compounds.

Jason's other prior experiences includes work as a scientist in the academic laboratory of Dr. Lisa Spencer at Beth Israel Deaconess Medical Center/Harvard Medical School where he studied eosinophil mechanisms predominantly focused on respiratory allergic inflammation and gastrointestinal disorders. Jason also worked as a research and development scientist at Celtaxsys, Inc., a start-up biotech, developing directed chemotaxis applications of neutrophils for various platforms and disease indications.

Jason holds a Bachelor of Science in Biomedical Engineering from Georgia Institute of Technology.

Jason is based in the New York office.

Back to top